Vyvgart® Hytrulo

Vyvgart® Hytrulo is a combination of efgartigimod alfa, a neonatal Fc receptor blocker, and hyaluronidase, an endoglycosidase, indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive. (1)

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Vyvgart® Hytrulo Referral Form